FREE ACCESS

Sign in with Google to continue in IP News.

Google SSO gives you the quickest path into the IIPLA newsroom, your reading access, and member-level continuity across articles. The full login page is still available if you prefer another option.

By continuing you agree to our terms and privacy policy.

Already have an account? Log in · Create account

Members-only content

IIPLA News
Monday, May 11, 2026

Indian Pharma Industry Calls for Enhanced Support Amid USTR Special 301 Report Concerns

Pharmaceutical exporters urge government incentives for formulations to maintain global competitiveness despite minimal legal risks from USTR listing

IIPLA News Deskanonymous access0 articles left this week
Indian Pharma Industry Calls for Enhanced Support Amid USTR Special 301 Report Concerns
Sign In To Continue

You have reached the guest article limit.

Unlock more of the IIPLA newsroom by signing in with SSO or joining as a member.

India’s pharmaceutical sector faces scrutiny in the latest USTR Special 301 Report over intellectual property rights enforcement, particularly in formulations. Industry leaders stress compliance with WTO norms and advocate for policy measures to protect and promote the formulations segment, highlighting the sector’s v…
Related Coverage

Continue in the newsroom

Back to newsroom
PatentsUK

Companies House and IPO Alert Businesses to Beware of Fraudulent Payment Demands

Companies House and the Intellectual Property Office (IPO) have jointly issued a warning to UK businesses about unsolicited payment requests. These fraudulent invoices often mimic official correspondence, demanding inflated fees for services that are either free or available at lower costs through legitimate governmen…

Friday, May 22, 2026